Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы

N. U. Tadjieva

Работ: 7

Tashkent Medical Academy, Tashkent, Republic of Uzbekistan

  1. Antibiotic use and knowledge in the community of Yemen, Saudi Arabia, and Uzbekistan

    Tatiana Belkina, Abdullah Al Warafi, Elhassan Hussein Eltom Abdalla +3

    СтатьяAntibiotic Use and ResistanceThe Journal of Infection in Developing Countries2014Цитирований: 4
    ABI

  2. Effectiveness of Vaccination against Pneumococcal Infection in Uzbekistan: a Preliminary Assessmant and Prognosis

    T. A. Daminov, L. N. Tuychiev, N. U. Tadjieva +1

    СтатьяPneumonia and Respiratory InfectionsCHILDREN INFECTIONS2018Цитирований: 1
    ABI

  3. PECULIARITIES OF THE PNEUMOCOCCAL PNEUMONIAE IN CHILDREN

    T. A. Daminov, L. N. Tuychiev, N. U. Tadjieva +1

    СтатьяPneumonia and Respiratory InfectionsDOAJ (DOAJ: Directory of Open Access Journals)2015Цитирований: 0
    ABI

  4. A clinical case of coinfection of COVID-19 and tropical malaria

    L. N. Tuychiev, М. Д. Ахмедова, N. U. Tadjieva +4

    СтатьяCOVID-19 epidemiological studiesJournal Infectology2023Цитирований: 0
    ABI

  5. Obtaining and Characterization of Experimental Diagnostic Brucellosis Rabbit Sera for the Development of a National Standard for Brucellosis Serum

    L. N. Tuychiev, B. M. Tadjiev, N. U. Tadjieva +5

    СтатьяBrucella: diagnosis, epidemiology, treatmentEpidemiology and Vaccinal Prevention2024Цитирований: 0
    ABI

  6. Purulent-inflammatory manifestations in the oropharynx in children with infectious mononucleosis

    L. N. Tuychiev, N. U. Tadjieva, G. T. Shermukhamedova +1

    СтатьяViral-associated cancers and disordersCHILDREN INFECTIONS2024Цитирований: 0
    ABI

  7. Technology for Producing Hyperimmune Agglutinating Sera against Salmonella using Various Immunization Schemes and Studying the Biochemical and Immunological Parameters of the Sera

    L. N. Tuychiev, B. M. Tadjiev, N. U. Tadjieva +5

    СтатьяSalmonella and Campylobacter epidemiologyEpidemiology and Vaccinal Prevention2025Цитирований: 0
    ABI